Your browser doesn't support javascript.
loading
Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study.
Al Taweel, Bader; Cassese, Gianluca; Khayat, Salah; Chazal, Maurice; Navarro, Francis; Guiu, Boris; Panaro, Fabrizio.
Afiliación
  • Al Taweel B; Department of Digestive Surgery and Liver Transplantation, Montpellier University Hospital, 34090 Montpellier, France.
  • Cassese G; Department of Clinical Medicine and Surgery, Division of Minimally Invasive and Robotic HPB Surgery and Transplantation Service, University of Naples "Federico II", 80131 Naples, Italy.
  • Khayat S; Department of Digestive Surgery and Liver Transplantation, Montpellier University Hospital, 34090 Montpellier, France.
  • Chazal M; Department of Visceral and Digestive Surgery, Centre Hospitalier de Perpignan, 66000 Perpignan, France.
  • Navarro F; Department of General and Visceral Surgery, Centre Hospitalier Princesse Grace, 98000 Monaco, Monaco.
  • Guiu B; Department of Digestive Surgery and Liver Transplantation, Montpellier University Hospital, 34090 Montpellier, France.
  • Panaro F; Department of Diagnostic and Interventional Radiology, Montpellier University Hospital, 34090 Montpellier, France.
Cancers (Basel) ; 16(11)2024 May 23.
Article en En | MEDLINE | ID: mdl-38893103
ABSTRACT

Background:

Liver venous deprivation (LVD) is a recent radiological technique that has shown promising results on Future Remnant Liver (FRL) hypertrophy. The aim of this retrospective study is to compare the segmentary hypertrophy of the FRL after LVD and after portal vein embolization (PVE).

Methods:

Patients undergoing PVE or LVD between April 2015 and April 2020 were included. The segmentary volumes (seg 4, seg2+3 and seg1) were assessed before and after the radiological procedure.

Results:

Forty-four patients were included 26 undergoing PVE, 10 LVD and 8 eLVD. Volume gain of both segment 1 and segments 2+3 was significantly higher after LVD and eLVD than after PVE (segment 1 27.33 ± 35.37 after PVE vs. 38.73% ± 13.47 after LVD and 79.13% ± 41.23 after eLVD, p = 0.0080; segments 2+3 40.73% ± 40.53 after PVE vs. 45.02% ± 21.53 after LVD and 85.49% ± 45.51 after eLVD, p = 0.0137), while this was not true for segment 4. FRL hypertrophy was confirmed to be higher after LVD and eLVD than after PVE (33.53% ± 21.22 vs. 68.63% ± 42.03 vs. 28.11% ± 28.33, respectively, p = 0.0280).

Conclusions:

LVD and eLVD may induce greater hypertrophy of segment 1 and segments 2+3 when compared to PVE.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza